Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 804-811

  Wang, J ^a   Green, P S ^a   Simpkins, J W ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

17 estradiol; 3 nitroproprionic acid; ATP depletion; Mitochondrial membrane potential; Reactive oxygen species

Indexed keywords

3 NITROPROPIONIC ACID; ADENOSINE TRIPHOSPHATE; ESTRADIOL; GLUCOSE; HYDROGEN PEROXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; BRAIN METABOLISM; CELL MEMBRANE POTENTIAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIA; MITOCHONDRION; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; ENZYME INHIBITORS; ESTRADIOL; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; NEUROBLASTOMA; NITRO COMPOUNDS; PROPIONIC ACIDS; REACTIVE OXYGEN SPECIES; SUCCINATE DEHYDROGENASE; TUMOR CELLS, CULTURED; UNCOUPLING AGENTS;

EID: 0034996927     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00271.x     Document Type: Article

References (46)

1. Astiazaran A. M., Ochoa B. and Lacort M. (1988) Estradiol-produced modifications on the response to glucose hepatocytes from fasted rats. Biochem. Med. Metab. Biol. 40, 197-203.
2. Astiazaran A. M., Chico Y., Ruiz M. B., Alonso M. T., Ochoa B. and Lacort M. (1989) Metabolic changes due to the in vitro addition of estradiol in rat hepatocytes. Rev. Esp. Fisiol. 45, 19-24.
3. Beal M. F. (1994) Neurochemistry and toxin models in Huntington's disease. Curr. Opin. Neurol. 7, 542-547.
4. Beal M. F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
5. Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1366, 211-223.
6. Behl C., Widmann M., Trapp T. and Holsboer F. (1995) 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
7. Binienda Z., Simmons C., Hussain S., Slikker W. Jr and Ali S. F. (1998) Effect of acute exposure to 3-nitroproprionic acid on activities of endogenous antioxidants in the rat brain. Neurosci. Lett. 251, 173-176.
8. Brodie A. E. and Reed D. J. (1990) Cellular recovery of glyceraldehyde-3-phosphate dehydrogenase activity and thiol status after exposure to hydroperoxides. Arch. Biochem. Biophys. 276, 212-218.
9. Demonacos C. V., Karayanni N., Hatzoglou E., Tsiriyiotis C., Spandidos D. A. and Sekeris. C. E. (1996) Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61, 226-232.
10. Diaz-Flores M., Baiza-Gutman L. A., Pedron N. N. and Hicks J. J. (1999) Uterine glutathione reductase activity: modulation by estrogens and progesterone. Life Sci. 65, 2481-2488.
11. Du C., Hu R., Csernansky C. A., Hsu C. Y. and Choi D. W. (1996) Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16, 195-201.
12. Emaus P. K., Grunwald R. and Lemaster J. J. (1986) Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim. Biophys. Acta 23, 436-448.
13. Fink S. L., Ho D. Y. and Sapolsky R. M. (1996) Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture. Exp. Neurol. 138, 298-304.
14. Geddes J. W., Bondada V. and Pang Z. (2000) Mechanism of 3-nitroproprionic acid neurotoxicity, in Mitochondrial Inhibitors and Neurodegenerative Disorders (Sandberg P. R., Nishino H. and Borlongan C. V., eds), pp. 107-120. Humana Press, Totowa, NJ.
15. Goodman Y., Bruce A. J., Cheng B. and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
16. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
17. Green P. S. and Simpkins J. W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Devl. Neurosci. 18, 347-358.
18. Green P. S., Bishop J. and Simpkins J. W. (1997) 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17, 511-515.
19. Gunter T. E. and Pfeiffer D. R. (1990) Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258, C755-C786.
20. Hall E. D., Pazara K. E. and Linseman K. L. (1991) Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11, 292-298.
21. Hansford R. G. (1985) Relation between mitochondrial calcium transport and control of energy metabolism. Rev. Physiol. Biochem. Pharmacol. 102, 1-72.
22. Johnson L. V., Walsh M. L. and Chen L. B. (1980) Localization of mitochondria in living cells with rhodamine 123. Proc. Natl Acad. Sci. USA 77, 990-994.
23. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50, 522-530.
24. Lacort M., Leal A. M., Liza M., Martin C., Martinez R. and Rniz-Larrea M. B. (1995) Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 30, 141-146.
25. Lemasters J. J., Nieminen A. L., Qian T., Trost L. C. and Herman B. (1997) The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol. Cell Biochem. 174, 159-165.
26. McCormack J. G., Halestrap A. P. and Demon R. M. (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70, 391-425.
27. Mattson M. P., Robinson N. and Guo Q. (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8, 3817-3821.
28. Melov S. (2000) Mitochondrial oxidative stress, physiologic consequences and potential for a role in aging. Ann. NY Acad. Sci. 908, 219-225.
29. Mills J. C., Nelson D., Erecinska M. and Pittman R. N. (1995) Metabolic and energetic changes during apoptosis in neural cells. J. Neurochem. 65, 1721-1730.
30. Miura T., Muraoka S. and Ogiso T. (1996) Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids 61, 379-383.
31. Nakano M., Sugioka K., Naito I., . Takekoshi S. and Niki E. (1987) Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochem. Biophys. Res. Commun. 142, 919-924.
32. Nishino H., Nakajima K., Kumazaki M., Fukuda A., Muramatsu K., Deshpande S. B., Inubushi T., Morikawa S., Borlongan C. V. and Sanberg P. R. (1998) Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci. Res. 30, 303-312.
33. Pang Z. and Geddes J. W. (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17, 3064-3073.
34. Ramirez V. D., Zheng J. and Siddique K. M. (1996) Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: fantasy or reality. Cell Mol. Neurobiol. 16, 175-198.
35. Seo S. Y., Kim E. Y., Kim H. and Gwag B. J. (1999) Neuroprotective effect of high glucose against NMDA, free radical, and oxygen-glucose deprivation through enhanced mitochondrial potentials. J. Neurosci. 19, 8849-8855.
36. Shi J. and Simpkins J. W. (1997) 17β-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am. J. Physiol. 272, E1016-E1022.
37. Shi J., Zhang Y. Q. and Simpkins J. W. (1997) Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp. Brain Res. 117, 200-206.
38. Simpkins J. W., Rajakumar G., Zhang Y. Q., Simpkins C. E., Greenwald D., Yu C. J., Bodor N. and Day A. L. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87, 724-730.
39. Singer C. A., Figueroa-Masot X. A., Batchelor R. H. and Dorsa D. M. (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463.
40. Sugioka K., Shimosegawa Y. and Nakano M. (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 210, 37-39.
41. Tatton W. G. and Olanow C. W. (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim. Biophys. Acta 1410, 195-213.
42. 2. Mol. Cell Biochem. 129, 57-65.
43. Yang S. H., Shi J., Day A. L. and Simpkins J. W. (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31, 745-750.
44. Zeevalk G. D., Bernard L. P. and Nicklas W. J. (1998) Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J. Neurochem. 70, 1421-1430.
45. +-ATPase of porcine cortex. Eur. J. Pharm. 368, 95-102.
46. Zheng J. and Ramirez V. D. (1999b) Purification and identification of an estrogen binding protein from rat brain: oligomycin-sensitivity-conferring protein (OSCP), a subunit of mitochondrial FOF1-ATP synthase/ATPase. J. Steroid Biochem. Mol. Biol. 68, 65-75.